Emmanuel Stip, MD, MSc
- 6Articles
- 17.9KReads
- 2000–2017Active
- 15Collaborators
- 40Citations
About
Emmanuel Stip, MD, MSc, has published extensively on schizophrenia, schizoaffective disorders, and addiction, focusing on topics such as long-acting injectable antipsychotics, high-dose quetiapine safety, and SSRI add-on therapy for negative symptoms of schizophrenia. His work includes clinical trials, meta-analyses, and neuroimaging studies investigating affect regulation and antipsychotic mechanisms. Stip's research contributions span from 2000 to 2017 and have appeared in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
